Multicenter evaluation of the hemostatic activity of emicizumab in patients with severe hemophilia A
Laurie Josset, Alexandre Leuci, Maissaa Janbain, Anaëlle De-Wreede, Stéphanie Desage, Anne Lienhart, Valérie Bin, Dorothée Lebert, Xavier Delavenne, Yesim Dargaud
Topics & Concepts
MedicineBlood coagulation factorsBreakthrough bleedingHemostasisHemostaticsHemostatic AgentMulticenter studyInternal medicineCoagulationResearch methodologyRandomized controlled trialPopulationFamily planningEnvironmental healthHemophilia Treatment and ResearchBlood Coagulation and Thrombosis MechanismsBlood properties and coagulation